Advanced Micro Devices Stock Rebounds, Analyst Sets $377 Target
Shares of Advanced Micro Devices (NASDAQ: AMD) rebounded in pre-market trading, rising 4.14% to $232.80 after a significant weekly decline. The surge in optimism is supported by a new price target from Raymond James, which set a $377 objective for the stock, indicating a potential increase of 83% from its current price of $206.02.
The pre-market gain follows a period where the stock had dropped 11.27% over the past week, closing at $223.55. During the most recent trading day, AMD's stock price was $206.02, a decrease of 7.84%. The stock fluctuated between a low of $205.29 and a high of $234.25.
A positive shift in investor sentiment across the semiconductor sector is partly attributed to better-than-expected third-quarter results from competitor Nvidia. Nvidia's strong performance has eased concerns about a potential slowdown in spending related to artificial intelligence, benefiting other chipmakers like AMD.
Over the past year, AMD's stock has seen a high of $267.08 and a low of $76.48. The company's market capitalization is approximately $334.37 billion, with a trading volume of 63.79 million shares.
Further information is available regarding AMD's history, its corporate vision, financial health, and its investor profile.
Advanced Micro Devices, Inc. (AMD) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.